Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Zhanjun, Guo"'
Autor:
Jiasong Li, Fang Ding, Shasha Zhang, Yuanyuan Jia, Tianhang Zhang, Siqi Wang, Qingyi Liu, Zhanjun Guo
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Gastric cancer is a significant global malignancy with poor prognosis. Although the emergence of immune checkpoint inhibitors (ICIs) prolonged the duration of survival, resistance and progression are inevitable. We aim to evaluate
Externí odkaz:
https://doaj.org/article/fc21bdc3bdd845f48e790c188a403155
Publikováno v:
Frontiers in Plant Physiology, Vol 2 (2024)
In Synechocystis sp. PCC 6803 (S. 6803), two types of phycobilisome (PBS) complexes, CpcG-PBS and CpcL-PBS, function to harvest light energy for photosynthetic reaction centers (RCs), photosystem I (PSI) and photosystem II (PSII). The compositional d
Externí odkaz:
https://doaj.org/article/77b48f4366914041b2cbc23bc6090e98
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionChronic viral infection may lead to an immunosuppressive microenvironment, whereas the association between virus-related indicators and treatment response in hepatocellular carcinoma(HCC) patients undergoing immune checkpoint inhibitors(I
Externí odkaz:
https://doaj.org/article/2ba8e75ac99b41ba99945aa9afcc9c61
Autor:
Jingjing Zhang, Lei Wang, Shasha Zhang, Ruijie Cao, Yufei Zhao, Yue Zhao, Yanrong Song, Zhanjun Guo
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Immune checkpoint inhibitors (ICIs) are commonly used in conjunction with chemotherapy to improve treatment outcomes for patients with gastric cancer. Since AFP could influence immunity by both inhibiting natural killer (NK) cells
Externí odkaz:
https://doaj.org/article/5ccf58e0da7e44569ab6271b70cb3bd4
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThyroid immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) treatment appear to correlate with a better prognosis. We aimed to investigate clinical biomarkers associated with thyroid irAEs.MethodsWe retro
Externí odkaz:
https://doaj.org/article/fd95a66a1c3e42d5b5ce60747e8f82aa
Autor:
Minli Qu, Linhui Zuo, Mengru Zhang, Peng Cheng, Zhanjun Guo, Junya Yang, Changjun Li, Jing Wu
Publikováno v:
Cell Death and Disease, Vol 14, Iss 6, Pp 1-15 (2023)
Abstract Tau hyperphosphorylation in hippocampal neurons has an important pathogenetic role in the development of diabetic cognitive dysfunction. N6-methyladenosine (m6A) methylation is the most common modification of eukaryotic mRNA and is involved
Externí odkaz:
https://doaj.org/article/c73afb9ac08c4a668cd711e8dae40976
Autor:
Jingjing Zhang, Shasha Zhang, Shuo Xu, Xiaoyun Zhang, Jiasong Li, Zhengzheng Ji, Qingyi Liu, Zhanjun Guo
Publikováno v:
Iranian Journal of Immunology, Vol 20, Iss 2, Pp 240-246 (2023)
Immune Checkpoint Inhibitors (ICIs) have dramatically revolutionized the therapeutic approaches by which we treat a series of cancers accompanied by immune-related adverse events (irAEs). Herein, we reported an intrahepatic cholangiocarcinoma male pa
Externí odkaz:
https://doaj.org/article/38a01c89363745baa63791fd0ede2922
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 36, Iss 1, Pp 370-378 (2022)
AbstractDicer is an RNaseIII in microRNA processing that modulates multiple biological processes including tumorigenesis. We have shown that Dicer could inhibit the growth of hepatocellular carcinoma (HCC) previously [Zhang L, Wang C, Liu S, Zhao Y,
Externí odkaz:
https://doaj.org/article/a2bc3f6719894ef2a942f6338921f2a2
Autor:
Xiaoyun Zhang, Shuo Xu, Jiaqi Wang, Yalei Lv, Na Wang, Ruixue Lai, Ziyue Sha, Qun Zhao, Zhanjun Guo
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) has shown remarkable benefit in the treatment of a range of cancer types, although it may initiate immune related adverse events (irAEs) in patients. Some studies have shown that there is a clos
Externí odkaz:
https://doaj.org/article/e3ef4da042f048b19236d0f970ac684c
Autor:
Yue Zhao, Rui Song, Yuanyuan Jia, Xiaoyun Zhang, Shasha Zhang, Chensi Wu, Ruixing Zhang, Zhanjun Guo
Publikováno v:
Current Oncology, Vol 29, Iss 9, Pp 6610-6627 (2022)
Fluoropyrimidine plus platinum (FP) and taxanes plus platinum (TP) are standard treatments for esophageal cancer (EC). This systematic review and meta-analysis aim to explore the difference in the therapeutic effect and toxicity of FP and TP regimens
Externí odkaz:
https://doaj.org/article/20c443b881844fc7be6e827c88780830